HUTCHMED (China) (HCM) Non-Current Deffered Revenue (2016 - 2025)

HUTCHMED (China) (HCM) has disclosed Non-Current Deffered Revenue for 9 consecutive years, with $20.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Deffered Revenue fell 58.43% to $20.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $20.1 million, a 58.43% decrease, with the full-year FY2025 number at $20.1 million, down 58.43% from a year prior.
  • Non-Current Deffered Revenue was $20.1 million for Q4 2025 at HUTCHMED (China), down from $48.4 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $69.5 million in Q4 2023 to a low of $190000.0 in Q4 2022.
  • A 4-year average of $34.6 million and a median of $34.3 million in 2024 define the central range for Non-Current Deffered Revenue.
  • Peak YoY movement for Non-Current Deffered Revenue: soared 36468.42% in 2023, then crashed 58.43% in 2025.
  • HUTCHMED (China)'s Non-Current Deffered Revenue stood at $190000.0 in 2022, then skyrocketed by 36468.42% to $69.5 million in 2023, then plummeted by 30.29% to $48.4 million in 2024, then plummeted by 58.43% to $20.1 million in 2025.
  • Per Business Quant, the three most recent readings for HCM's Non-Current Deffered Revenue are $20.1 million (Q4 2025), $48.4 million (Q4 2024), and $69.5 million (Q4 2023).